A. Corey
Impact in
- Immunology top 10%
- interferon and immune responses
- Phagocytosis and Immune Regulation
- Cancer Research top 10%
- NF-κB Signaling Pathways
Papers in
-
- Cell death mechanisms and regulation 9
- Retinoids in leukemia and cellular processes 2
- Oncology 6
- Drug Transport and Resistance Mechanisms 3
- Co-authors
- Norma Lynn Fox (3 shared papers)Wendy Halpern (2 shared papers)Amita Patnaik (3 shared papers)Kristin Padavic (3 shared papers)Roger B. Cohen (2 shared papers)Amit M. Oza (5 shared papers)Lyly Le (5 shared papers)Sebastién J. Hotte (5 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)The Journal of Clinical Pharmacology (5 papers)Clinical Cancer Research (2 papers)British Journal of Clinical Pharmacology (2 papers)Clinical Pharmacokinetics (1 paper)
- Partner nations
- United StatesSpainCanada
In The Last Decade
A. Corey
30 papers receiving 944 citations
Peers
Comparison fields: 5 of 70
- Immunology 222
- Cancer Research 139
- Molecular Biology 672
- Oncology 241
- Biotechnology 66
Countries citing papers authored by A. Corey
This map shows the geographic impact of A. Corey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Corey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Corey more than expected).
Fields of papers citing papers by A. Corey
This network shows the impact of papers produced by A. Corey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Corey. The network helps show where A. Corey may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Corey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 254 | |
| 2 | 2007 | 199 | |
| 3 | 2008 | 163 | |
| 4 | 1998 | 58 | |
| 5 | 2013 | 29 | |
| 6 | 2006 | 28 | |
| 7 | 2004 | 22 | |
| 8 | 1997 | 20 | |
| 9 | 2004 | 20 | |
| 10 | 2005 | 19 | |
| 11 | 1999 | 18 | |
| 12 | 2005 | 16 | |
| 13 | 1999 | 15 | |
| 14 | 1990 | 14 | |
| 15 | 2000 | 10 | |
| 16 | 1999 | 10 | |
| 17 | 2004 | 10 | |
| 18 | 2004 | 10 | |
| 19 | 2008 | 10 | |
| 20 | 1999 | 9 |
About A. Corey
A. Corey is a scholar working on Molecular Biology, Oncology, Biotechnology, Pharmacology and Pharmacology, having authored 30 papers that have together received 971 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (9 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Cancer Research and Treatments (4 papers), Cardiac electrophysiology and arrhythmias (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Retinoids in leukemia and cellular processes (2 papers). The work is most often cited by research in Immunology (222 citations), Cancer Research (139 citations), Molecular Biology (672 citations), Oncology (241 citations) and Biotechnology (66 citations). A. Corey has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Norma Lynn Fox, Wendy Halpern, Amita Patnaik, Kristin Padavic, Roger B. Cohen, Amit M. Oza, Lyly Le, Sebastién J. Hotte, Monica Mita and Margaret von Mehren. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Clinical Pharmacology, Clinical Cancer Research, British Journal of Clinical Pharmacology and Clinical Pharmacokinetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.